EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population

Rachel Mittelstaedt iD, Sanjat Kanjilal iD, David Helekal, Gregory K Robbins, Yonatan H Grad iD

The Journal of Infectious Diseases · 15.04.2025 · 231 (4) · e708-e712

DOI: 10.1093/infdis/jiae634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.12.2024. Verfasst von Rachel Mittelstaedt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital. Hauptthemen laut MEDLINE: Doxycycline, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CDC HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among doxycycline postexposure prophylaxis (doxy-PEP)–eligible men, Staphylococcus aureus tetracycline nonsusceptibility is more prevalent than in the overall population and is associated with resistance to trimethoprim-sulfamethoxazole and clindamycin. Doxy-PEP may select for multidrug-resistant S aureus, underscoring the importance of surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineAnti-Bacterial AgentsStaphylococcal InfectionsStaphylococcus aureusPost-Exposure ProphylaxisTetracycline ResistanceHumansMaleMiddle AgedDrug Resistance, Multiple, BacterialAdultTrimethoprim, Sulfamethoxazole Drug CombinationMicrobial Sensitivity TestsYoung AdultAged

Stichwörter der Autor:innen

Staphylococcus aureusdoxy-PEPdoxycycline postexposure prophylaxis

Substanzen

DoxycyclineAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital.
  • Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health.
  • Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute.
  • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.

ORCID-Profile: Rachel Mittelstaedt, Sanjat Kanjilal, Yonatan H Grad

Förderung

  • NIAID NIH HHS
  • CDC HHS
  • National Institute of Allergy and Infectious Diseases
  • Centers for Disease Control and Prevention

Zitieren

APA

Mittelstaedt, R., Kanjilal, S., Helekal, D., Robbins, G. K., & Grad, Y. H. (2025). Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population. The Journal of Infectious Diseases, 231(4), e708-e712. https://doi.org/10.1093/infdis/jiae634

Vancouver

Mittelstaedt R, Kanjilal S, Helekal D, Robbins GK, Grad YH. Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population. The Journal of Infectious Diseases. 2025;231(4):e708-e712. doi:10.1093/infdis/jiae634

BibTeX
@article{Mittelstaedt2025,
  author = {Mittelstaedt, Rachel and Kanjilal, Sanjat and Helekal, David and Robbins, Gregory K and Grad, Yonatan H},
  title = {Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {4},
  pages = {e708--e712},
  doi = {10.1093/infdis/jiae634}
}
Kostenlos starten →